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Abstract 1 
Microtubules are critical for mitosis, cell motility, and protein and organelle transport, and are a 2 
validated target for anticancer drugs. However, tubulin regulation and recruitment in these 3 
cellular processes is less understood. Post-translational modifications of tubulin are proposed to 4 
regulate microtubule functions and dynamics. Although many such modifications have been 5 
investigated, tubulin methylations and enzymes responsible for methylation have only recently 6 
begun to be described. Here we report that N-lysine methyl transferase KMT5A 7 
(SET8/PR-Set7), which methylates histone H4K20, also methylates α-tubulin. Furthermore, the 8 
transcription factor LSF binds both tubulin and SET8, and enhances α-tubulin methylation in 9 
vitro, countered by FQI1, a specific small molecule inhibitor of LSF. Thus, the three proteins 10 
SET8, LSF, and tubulin, all essential for mitotic progression, interact with each other. Overall, 11 
these results point to dual functions for both SET8 and LSF not only in chromatin regulation, but 12 
also for cytoskeletal modification. 13 
 14 
Keywords: KMT5A/LSF/Lysine methylation/Transcription factor/Tubulin modification  15 
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Introduction 1 
Microtubules (MTs), the polymerized heterodimers of α-tubulin and β-tubulin, are major 2 
cytoskeletal components that play important roles in key cellular processes such as structural 3 
support, localization of organelles, and chromosome segregation (Janke, 2014;Verhey and 4 
Gaertig, 2007). A number of post-translational modifications (PTMs) of tubulins have been 5 
reported, which contribute to the functional diversity of MTs and affect MT dynamics and 6 
organization (Song and Brady, 2015). This led to the hypothesis of a tubulin code (Verhey et al., 7 
2007), where tubulin modifications specify biological outcomes through changes in higher-order 8 
microtubule structure by recruiting and interacting with effector proteins. Notably, tubulin 9 
methylation has been less studied than other types of tubulin modification, such as tyrosination, 10 
glutamylation, glycylation, acetylation, and phosphorylation, although in the parallel histone 11 
code hypothesis, methylation is the most common and well-understood modification. 12 
  SET8/PR-Set7 is a N-lysine methyltransferase responsible for the monomethylation of 13 
both histone and non-histone proteins in higher eukaryotes (Dillon et al., 2005). It is functionally 14 
characterized as a histone H4 lysine 20-specific monomethyltransferase (Fang et al., 2002); this 15 
modification is a specific mark for transcriptional repression and is also enriched during mitosis 16 
(Nishioka et al., 2002;Rice et al., 2002). SET8 is required for cell proliferation, chromosome 17 
condensation, and cytokinesis, since deletion or RNAi mediated depletion of the enzyme impairs 18 
all these functions. Previous findings, in particular, suggested that SET8 and H4K20me1 are 19 
required for mitotic entry (Wu and Rice, 2011). SET8 also mediates monomethylation of other 20 
substrates, including p53, which results in repression of p53 target genes (Shi et al., 2007). 21 
However, how H4K20me1 is regulated and how it functions to promote cell cycle progression 22 
remains an open question, including the possibility that other non-histone substrates may be 23 
involved. 24 
LSF, previously characterized widely as a transcription factor, is an oncogene in 25 
hepatocellular carcinoma, being signficantly overexpressed in hepatocellular carcinoma cell lines 26 
and patient samples (Fan et al., 2011;Gu et al., 2015;Kim et al., 2017;Seol et al., 2016;Yoo et 27 
al., 2010;Zhang et al., 2017), as well as in other cancer types (Kotarba et al., 2018). LSF is also 28 
generally required for cell cycle progression and cell survival (Hansen et al., 2009;Powell et al., 29 
2000;Rajasekaran et al., 2015). Initially, LSF was described as a regulator of G1/S progression 30 
(Powell et al., 2000) and essential for inducing expression of the gene encoding thymidylate 31 
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synthase (TYMS) in late G1. The additional involvement of LSF in mitosis resulted from 1 
characterization of the effects of Factor Quinolinone Inhibitor 1 (FQI1), a specific small 2 
molecule inhibitor of LSF (Rajasekaran et al., 2015). FQI1 not only abrogates the DNA-binding 3 
and corresponding transcriptional activities of LSF (Rajasekaran et al., 2015), but also specific 4 
LSF-protein interactions (Chin et al., 2016). Finally, FQI1 inhibits growth of hepatocellular 5 
carcinoma tumors in multiple mouse models, and causes cell death via mitotic defects in 6 
hepatocellular carcinoma cell lines (Grant et al., 2012;Rajasekaran et al., 2015). 7 
In this study, we demonstrate that these three regulators of mitosis, SET8, LSF, and 8 
tubulin, all interact with each other both in vitro and within cells. Furthermore, we demonstrate 9 
that SET8 is a microtubule-associated methyltransferase that methylates lysines on α-tubulin. In 10 
parallel to how transcription factors stimulate histone modification by interacting both with the 11 
chromatin writers and the DNA, LSF stimulates methylation of tubulin by SET8. These results 12 
suggest that LSF and SET8 have biological implications beyond gene transcription and histone 13 
methylation, respectively. 14 
 15 
Results 16 
SET8 directly interacts with tubulin 17 
Analysis of two commercial tubulin preparations (>97% and >99 % pure, respectively) by mass 18 
spectroscopy identified anticipated associated proteins (e.g. MAP1, MAP2), but surprisingly also 19 
peptides covering SET8 (Appendix Fig S1A; Appendix Table S1). The presence of SET8 in 20 
these preparations was indicated by immunoblotting, although it is a minor component 21 
(Appendix Fig S1B). This raised the question of whether SET8 might target MT-related 22 
substrates. Indeed, initial overexpression of GFP-SET8 in a COS7 cell line indicated that the 23 
majority of GFP-SET8 was localized in the cytoplasm (Fig 1A). Upon screening for association 24 
with various cytoplasmic structural features by staining with relevant fluorescence dyes or 25 
antibodies along with GFP-SET8 expression, GST-SET8 significantly co-localized only with α-26 
tubulin, indicating MTs. MT co-localization was observed at stages through the cell cycle (Fig 27 
1A, Appendix Fig S1C). Most obvious was in G1 phase, when SET8 exhibited the same pattern 28 
as the filamentous tubulin distributed throughout the cytoplasm, emphasized by the yellow in the 29 
merged image. In S phase, as expected from previous studies, some SET8 was also nuclear (Fig 30 
1A). Although SET8 is often considered to be a nuclear protein, localization of SET8 also in the 31 
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cytoplasm of human cells has been documented by others, in a cell type-specific manner (Thul et 1 
al., 2017). Furthermore, biochemical fractionation confirmed localization of endogenous SET8 2 
in both the nucleus and the cytoplasm of human HEK293T cells (Fig 1B), which were used in 3 
subsequent experiments. 4 
To determine whether endogenous cellular SET8 associates with tubulins, we 5 
immunoprecipitated protein complexes from HEK293T cell extracts. Using antibody against 6 
SET8, α-tubulin was also precipitated, as well as β-tubulin, although to a considerably lesser 7 
extent (Fig 1C). Conversely, upon expression of Flag-tagged α-tubulin or β-tubulin in the cells, 8 
endogenous SET8 co-immunoprecipitated with both, to roughly similar extents compared to the 9 
level of expression of the tagged tubulin (Fig 1D). As α- and β-tubulins stably heterodimerize in 10 
cells, in vitro experiments were required in order to determine whether either of these 11 
interactions was direct. To this end, purified recombinant proteins fusing maltose binding protein 12 
(MBP) to either α-tubulin (TUBA1A) or β-tubulin (TUBB) were individually tested for 13 
interactions with His-tagged SET8 purified from E. coli. SET8 directly interacted only with 14 
α-tubulin, but not with β-tubulin (Fig 1E). Conversely, recombinant proteins fusing glutathione 15 
S-transferase (GST) to either full-length, or the N- or C-terminal overlapping portions of human 16 
SET8 were tested for interactions in vitro with a purified tubulin preparation. The purified 17 
heterodimeric tubulin interacted only with the full-length and N-terminal portion of SET8, even 18 
though th C-terminal SET8 fusion protein was present at a higher level than the others (Fig 1F), 19 
indicating specificity of this interaction. Taken together, these data demonstrate that α-tubulin 20 
and SET8 directly interact with each other, whereas β-tubulin is only in a complex with SET8 in 21 
the presence of α-tubulin. 22 
 23 
SET8 methylates α-tubulin 24 
SET8 was characterized historically as a nucleosomal H4K20 specific methyltransferase, and 25 
subsequently as a regulator of the non-histone protein p53. However, since SET8 bound strongly 26 
to α-tubulin, we tested whether tubulins could be a novel substrate of the enzyme. Purified 27 
mammalian α/β-tubulin was incubated with the cofactor S-adenosyl-L-[methyl-3H] methionine 28 
(AdoMet) and purified, recombinant GST-SET8. In the presence of both SET8 and AdoMet, 29 
radioactivity was incorporated into a protein band migrating at the position of α- and β-tubulins, 30 
in addition to a less pronounced automethylation of GST-SET8 (Fig 2A, lane 3), but no 31 
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radioactive product was present at the position of α- and β-tubulins when either tubulin or SET8 1 
was omitted from the reaction (Fig 2A, lanes 2 and 4). Interestingly, when histone H4 was also 2 
included in the reaction, the amount of tubulin modification was reduced (Fig 2A, lane 1), 3 
indicating that histone H4 strongly competed with tubulins for the methylation activity of SET8. 4 
Furthermore, histone H4 also competed with SET8 itself as a substrate, as shown by the 5 
significant reduction in SET8 automethylation in the presence of histone H4.  6 
Since purified tubulin is composed of α-and β-tubulin heterodimers, we sought to 7 
determine which species is methylated by SET8. Recombinant fusion proteins of either α-tubulin 8 
or β-tubulin with MBP were purified and incubated with SET8 along with the radioactive methyl 9 
donor. Upon incubation of SET8 with α/β tubulin and AdoMet, both SET8 and tubulin(s) were 10 
labeled. However, only MBP-α-tubulin, but not MBP-β-tubulin was methylated, along with 11 
SET8 itself, when the individual recombinant proteins were tested (Fig 2B). These data indicate 12 
that α-tubulin is the target for SET8. Mass spectrometry was used to determine which lysine 13 
residue(s) of α-tubulin were methylated by SET8. In the control samples without exogenous 14 
SET8, lysine methylation of α-tubulin on K304, and of β-tubulin on K19 and K297 were 15 
detected (Appendix Fig S2A), none of which have previously been reported. As anticipated from 16 
the previous data (Fig 2B), incubation with exogenous SET8 did not induce detectable 17 
methylation at any other sites on β-tubulin. However, SET8 did induce methylation of three 18 
additional lysine residues of α-tubulin - K280, K311 and K352 - which were all monomethylated 19 
(Fig 2C, Appendix Fig S2A). Of these three lysines, only K311 is located on the outside surface 20 
of MTs, whereas K352 is at the interface between α-tubulin and the β-tubulin in the adjacent 21 
heterodimer, and K280 is on the inside surface of MTs (Fig 2D, Appendix Fig S2B,C). In 22 
addition, only the sequence surrounding K311 (RHGK311) resembles those of other known SET8 23 
target sequences: histone H4 (RHRK20) and p53 (RHKK382) (Shi et al., 2007). In contrast, the 24 
sequences of the other α-tubulin sites, SAEK280 and TGFK352, do not resemble other known 25 
physiological SET8 tarets. To determine the relative efficiency of targeting these lysines in vitro, 26 
each was independently mutated in the context of the full-length MBP-α-tubulin, and purified 27 
proteins were tested for incorporation of radioactivity upon incubation with SET8. In order to 28 
test the relevant degree of methylation by SET8 at the identified sites, each lysine was mutated 29 
indivually to serine, maintaining a similar structure and hydrophilicity, but removing the charge. 30 
Consistent with K311 being the best sequence match with other SET8 targets, only mutation of 31 
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K311 was no longer detectably modified by SET8, whereas mutation of K280, K304, or K352 1 
did not appreciably affect the amount of methylation of the substrates (Fig 2E). 2 
In order to test further the inherent targeting of the various α-tubulin sites by SET8, 3 
peptides spanning these three sites (K280, K311, K352), as well as K40, reported to be 4 
methylated by SETD2 (Park et al., 2016), and K304, modified in purified porcine tubulin 5 
(Appendix Fig S2A), were incubated with purified wild type SET8 in vitro. Only the K311-6 
containing peptide was robustly methylated (Appendix Fig S3A, Appendix Table S2). In 7 
addition, radioactive incorporation into the K311-containing peptide was absent when incubated 8 
with catalytically inactive SET8 (D338A) in vitro, and methylation abolished if the K311 residue 9 
was either mutated (K311A, K311S) or already modified (K311Me, K311Ac) (Appendix Fig 10 
S3B, Appendix Table S2). Although the in vitro targeting of the α-tubulin K311-containing 11 
peptide by SET8 is robust (Appendix Fig S3C), SET8 methylates histone H4 much more 12 
efficiently, consistent with the ability of Histone H4 to strongly compete against tubulin for 13 
methylation by SET8 (Fig 2A). In contrast, but consistent with the previous report (Park et al., 14 
2016), methylation by the only other reported tubulin methyltransferase, SETD2, of the α-tubulin 15 
K40-containing peptide was not detectable over background, despite some methylation of 16 
histone H3 by this enzyme in vitro (Appendix Fig S3D). 17 
Taken together, these observations indicated that SET8 methyltransferase has the 18 
capacity to directly methylate α-tubulin, particularly at K311. 19 
 20 
Transcription factor LSF associates with both SET8 and tubulin 21 
DNA-binding proteins recruit chromatin writers to modify histones (Brownell et al., 1996;Hassig 22 
and Schreiber, 1997;Struhl, 1999;Taunton et al., 1996), suggesting the possibility that tubulin-23 
binding proteins might similarly recruit SET8 to target sites on microtubules resulting in tubulin 24 
modification. Our previous studies showed that the transcription factor LSF interacts with 25 
DNMT1, and addition of an inhibitor of the LSF-DNMT1 interaction resulted in alterations in 26 
the genomic DNA methylation profile (Chin et al., 2016); this is consistent with recruitment of 27 
DNMT1 to DNA by LSF in order to facilitate DNA methylation at specific sites. Since DNMT1 28 
complexes with SET8, and both SET8 and LSF (Rajasekaran et al., 2015) are required for 29 
mitotic progression, we proposed the novel hypothesis that the transcription factor LSF might 30 
also recruit SET8 to microtubules in order to facilitate α-tubulin methylation by SET8. In support 31 
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of this hypothesis, there is precedent for some DNA-binding transcription factors also binding 1 
microtubules (Alexandrova et al., 1995;Dong et al., 2000;Giannakakou et al., 2000;Maxwell et 2 
al., 1991;Niklinski et al., 2000;Ziegelbauer et al., 2001), although for the purpose of 3 
sequestering the transcription factors in the cytoplasm and/or facilitating their transport into the 4 
nucleus.  5 
To test this hypothesis, multiple assays were initially performed to evaluate whether LSF 6 
interacts with SET8 and tubulin(s). In vitro, direct interaction between recombinant, purified 7 
SET8 and purified LSF was evaluated by a GST pull-down assay (Fig 3A). Using fusion proteins 8 
between GST and either full length SET8, or its N- or C-terminal fragments, the His-LSF bound 9 
specifically to the N-terminal region of SET8 (Fig 3A), the same domain that bound purified 10 
tubulin (Fig 1F). The binding of purified α/β-tubulin to purified GST-LSF was also evaluated 11 
and mapped to specific regions within LSF. Both α- and β-tubulins showed similar binding 12 
profiles to the panel of LSF fusion proteins, as expected given their stable heterodimeric 13 
structure (Fig 3B). Binding of tubulins to the full-length GST-LSF was greater than to the control 14 
GST, although weak compared to some of the other fusion proteins, due to the sensitivity of the 15 
full-length GST-LSF fusion protein to cleavage in bacterial culture, resulting in significant 16 
purification of the GST domain alone in the preparation. However, the tubulins interacted 17 
strongly with two specific domains of LSF whose GST fusion proteins were stable: the DNA 18 
binding domain (DBD), and to a lesser extent, the SAM domain (Fig 3B). Further analysis 19 
suggests that it is the C-terminal portion of the DBD that contains the tubulin interaction surface 20 
in this domain, since the GST-LSF 2 protein also binds both tubulins to a high degree. Finally, 21 
purified His-LSF also interacted in parallel assays with purified recombinant full-length GST-α-22 
tubulin (Fig 3C). These in vitro protein-protein interaction results indicate that all pairwise 23 
interactions among SET8, LSF, and α-tubulin occur through direct binding with each other. 24 
To examine whether interactions of LSF with both SET8 and tubulin also take place in 25 
cells, multiple approaches were taken. First, upon co-expression of GFP-SET8 and 3xFlag-26 
tagged LSF in transient transfection assays, the two proteins significantly co-localized, 27 
predominantly in the cytoplasm (Fig 3D). Second, the presence of complexes between 28 
endogenous cellular proteins were tested by co-immunoprecipitation experiments using lysates 29 
from the human HEK293 cell line. With antibodies against endogenous LSF, but not control 30 
antibodies, both endogenous SET8 and endogenous α-tubulin co-immunoprecipitated with LSF 31 
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(Fig 3E). Reciprocally, SET8 antibodies, but not control antibodies, also co-immunoprecipitated 1 
endogenous LSF (Fig 3F). Finally, the possibility of relevant LSF-tubulin interactions was 2 
investigated by analyzing whether LSF was present in commercial, highly purified tubulin 3 
preparations. These preparations are obtained in part by multiple rounds of 4 
polymerization/depolymerization of the tubulin, and are more than 97-99% pure. They are well 5 
known to contain additional proteins that are defined as microtubule-associated proteins (MAPs). 6 
Immunoblots using a LSF monoclonal antibody did indeed detect a band comigrating with LSF, 7 
albeit at a very low level (Fig 3G). LSF was reproducibly detected in this manner in multiple 8 
commercially purified preparations of tubulin. 9 
Taken together, these results demonstrate that LSF interacts directly with both SET8 and 10 
α-tubulin in vitro, and also associates with both in vivo. Furthermore, LSF, although a 11 
transcription factor, appears to be a previously unidentified MAP. 12 
 13 
LSF promotes tubulin methylation by SET8 14 
The demonstration of pairwise, physical interactions between LSF, tubulin, and SET8 set the 15 
stage for directly testing the hypothesis that LSF could mediate the methylation of α-tubulin by 16 
SET8. Thus, recombinant GST-SET8 and the methyl donor were incubated with tubulin in the 17 
presence of increasing concentrations of purified His-LSF (Fig 4A). Tubulin methylation 18 
increased upon increasing LSF from a 1:4 to 2:1 molar ratio of LSF:GST-SET8, suggesting that 19 
LSF can mediate tubulin methylation by SET8. Note that in this experiment, there was more 20 
SET8 relative to tubulin than in other experiments (Fig 4A, bottom), resulting in a greater degree 21 
of automethylation of SET8 compared to tubulin methylation (Fig 4A, top), presumably due to 22 
substrate competition between SET3 itself and α-tubulin. A similar experiment was performed 23 
using recombinant MBP-α-tubulin as substrate for SET8, which also showed that increasing 24 
levels of LSF enhanced methylation of the MBP-α-tubulin (Appendix Fig S4A). 25 
The LSF small molecule inhibitor, FQI1, inhibits LSF binding to DNA (Grant et al., 26 
2012), as well as binding of LSF to certain protein partners (Chin et al., 2016). To determine 27 
whether FQI1 would also diminish the interaction in cells between LSF and tubulin, cell lysates 28 
from vehicle- versus FQI1-treated cells were analyzed by co-immunoprecipitation assays. These 29 
demonstrated a significant reduction in the LSF-tubulin interaction after FQI1 incubation (Fig 30 
5B). Since FQI1 can inhibit the LSF-tubulin interaction in vivo, it was used to interrogate 31 
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whether the interaction of LSF and tubulin was important for stimulating the SET8-mediated 1 
methylation of tubulin in vitro. Since LSF is already present in the tubulin preparations, initially, 2 
FQI1 was added to reactions containing only SET8, methyl donor, and purified tubulin. Tubulin 3 
methylation decreased with increasing concentrations of FQI1 (Fig 5C), consistent with the 4 
presence of LSF and its ability to enhance SET8-dependent tubulin methylation. Whether FQI1 5 
specifically inhibits LSF in these assays was tested in two ways. First, it was demonstrated that 6 
the presence of FQI1 prevented any increase in tubulin methylation upon addition of purified 7 
His-LSF (Appendix Fig S4B, compare lanes 7 and 8). Second, the possibility that FQI1 directly 8 
inhibits SET8 catalytic activity was tested using Histone H4, instead of α-tubulin, as a substrate. 9 
Limiting amounts of histone H4 were added in this experiment to enhance the sensitivity of the 10 
assay. FQI1 did not inhibit methylation of histone H4 by SET8, in contrast to its effect on 11 
α-tubulin methylation (Fig 5D). In addition, when SET8 was incubated with whole cell extract in 12 
the presence of the radioactive methyl donor, FQI1 did not appreciably diminish methylation of 13 
any of the other proteins in the extract (Appendix Fig S4B, compare lanes 1 and 2). 14 
These data indicate that LSF enhances tubulin methylation by SET8, and conversely that 15 
FQI1, which abrogates the tubulin-LSF interaction (Fig 4B), impedes methylation of α-tubulin 16 
by SET8. Overall, these data support a model that LSF recruits SET8 to tubulin, and/or that LSF 17 
binding as a ternary complex to SET8 and tubulin activates the methylase activity of SET8 18 
already associated with tubulin (Fig 4E). To probe whether LSF recruits SET8 to tubulin, we 19 
again used FQI1 to disrupt the LSF-tubulin interactions. FQI1 did diminish co-20 
immunoprecipitation of endogenous tubulin with SET8 antibodies (Appendix Fig S4C), 21 
supporting the recruitment model. However, a caveat to this straightforward interpretation was 22 
that SET8 immunoprecipitation was also somewhat diminished, although less so, after 23 
incubation of the cells with FQI1. 24 
 25 
Discussion 26 
A number of post-translational modifications of microtubules are well established, including the 27 
enzymes responsible for these modifications. However, thus far, only limited insights have been 28 
obtained regarding their biological roles, and tubulin PTMs have generally remained less 29 
amenable to straightforward in vitro functional studies. A number of posttranslational 30 
modifications of tubulins have been reported, along with their modifying enzymes, including 31 
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acetylation of lysine 40 in α-tubulin by αTAT1 (MEC-17 in C. elegans), deacetylation of the 1 
same residue by Sirt2 (Sirtuin type2), HDAC5, and HDAC6, and polyglutamylation of both 2 
α- and β-tubulins at multiple C-terminal glutamate residues by TTLL4, 5, and 7 (Ikegami et al., 3 
2006;Janke et al., 2005). Although extensive research has been carried out on various modified 4 
sites and has identified the relevant enzymes, only one study has previously identified lysine 5 
methylation of tubulin (Park et al., 2016), which is the focus of this report. Walker’s group 6 
reported that SETD2, known as a histone methyltransferase for a chromatin activation mark, 7 
H3K36me3, also methylates α-tubulin at K40. Furthermore, the loss of SETD2-mediated tubulin 8 
methylation resulted in mitotic microtubule defects and genomic instability. Here, we describe a 9 
distinct, novel lysine methylation of α-tubulin at K311 and identify the enzyme responsible for 10 
its modification as SET8. In addition, we identify methylation of β-tubulin purified from 11 
mammalian brain at K19 and K297, and are pursuing identification of the enzymes responsible. 12 
Importantly, we also demonstrate the surprising finding that a transcription factor, LSF, 13 
moonlights as a microtubule-associated protein, and that it can recruit SET8 to tubulin and/or 14 
enhance its activity on tubulin to facilitate the modification. The recruitment mechanism mirrors 15 
mechanisms of targeting of histone writers to chromatin, expanding the model of the parallel 16 
nature between the generation of the histone and tubulin codes. Furthermore, these data indicate 17 
that transcription factors more generally may be able to regulate tubulin modifications, and 18 
thereby microtubule dynamics. Although several transcription factors have previously been 19 
reported to bind microtubules, including c-myc (Alexandrova et al., 1995;Niklinski et al., 2000), 20 
MIZ-1 (Ziegelbauer et al., 2001), p53 (Giannakakou et al., 2000;Maxwell et al., 1991), and 21 
Smads (Dong et al., 2000), in all these cases the biological relevance proposed or demonstrated 22 
was to sequester the transcription factors in the cytoplasm, and/or to help transport the 23 
transcription factor into the nucleus. Thus, all previous indications had to do with regulation of 24 
transcription activity, not of microtubule function. This is the first case in which binding of a 25 
transcription factor directly to microtubules would lead to altered microtubule modifications, and 26 
to altered function. We propose that this presents a new paradigm that may well occur with other 27 
transcription factors, as well. 28 
Tubulin PTMs are generally thought to regulate protein-protein interactions within the 29 
microtubule cytoskeleton, thereby regulating signaling events in the cell. To date, a large variety 30 
of microtubule associated proteins (MAPs) have been characterized, many of which stabilize and 31 
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destabilize microtubules, are associated with the coupling of molecular motors and microtubules, 1 
and play critical roles in spindle formation (Stanton et al., 2011).  2 
Proper mammalian cell cycle progression requires precise modulation of SET8 levels, 3 
which suggested that SET8 and H4K20me1 function as novel regulators of cell cycle 4 
progression, although the previous focus has been on regulation of S phase (Milite et al., 2016). 5 
With our demonstration that SET8 can also methylate α-tubulin, the roles of non-histone 6 
substrates must also be considered as causes for SET8-mediated regulation of the cell cycle, and 7 
in particular of mitosis when SET8 is most abundant (Rice et al., 2002). As in mammals, SET8 8 
is essential for life in D. melanogaster, as SET8 mutants die during larval development. 9 
However, upon replacement of all Drosophila histone H4 genes with multiple copies of a mutant 10 
histone H4K20A, the flies survived to adulthood without apparent DNA replication defects 11 
(McKay et al., 2015). Thus, contrary to the prevailing view, histone H4 was not the critical target 12 
for SET8. Given the minimal biological effects in Drosophila of mutating histone H4K20, we 13 
propose that α-tubulin methylation is a strong candidate for mediating critical SET8 14 
consequences. Notably, D. melanogaster and human α-tubulins are 98% identical with all the 15 
lysines throughout the sequence being conserved. 16 
Mitosis is viewed as a vulnerable target for inhibition in cancer (Komlodi-Pasztor et al., 17 
2012). In that light, it is notable that LSF promotes oncogenesis in hepatocellular carcinoma, the 18 
sixth most common cancer worldwide and the second highest cause of cancer-related death 19 
globally (Laursen, 2014). LSF is overexpressed in human hepatocellular carcinoma cell lines, 20 
and over 90% of human hepatocellular carcinoma patient samples, showing significant 21 
correlation with stages and grades of the disease (Yoo et al., 2010). The lead LSF inhibitor, 22 
FQI1, induces apoptosis in an aggressive hepatocellular carcinoma cell line in vitro and 23 
significantly inhibits tumor growth in multiple mouse hepatocellular carcinoma models, with no 24 
observable toxicity to normal tissues (Grant et al., 2012;Rajasekaran et al., 2015). These new 25 
findings that LSF interacts with tubulin and SET8, and that FQI1 disrupts the LSF-tubulin 26 
interaction, may be related to the impact of the LSF inhibitors in hepatocellular carcinoma cells 27 
and tumors. Expression both of particular tubulins (e.g. TUBA1B) and of SET8 are upregulated 28 
in hepatocellular carcinoma tumor samples, as compared to normal liver (Guo et al., 2012;Lu et 29 
al., 2013). Moreover, SET8 is required to maintain the malignant phenotype of various cancer 30 
types (Hou et al., 2016). Given the current lack of effective treatments, further investigation into 31 
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the relevance of the LSF-tubulin-SET8 pathway to hepatocellular carcinoma and other cancer 1 
types in which LSF is oncogenic may aid in targeted and effective treatment. 2 
Material and Methods 3 
Cell Culture, immunoprecipitation, and immunofluorescence 4 
HEK293T and COS7 cells were cultured in DMEM media supplemented with 10% fetal bovine 5 
serum. FQI1 (Millipore/Sigma #438210) treatment of HEK293T cells was for 24 hours at 37°C 6 
with 2.5 μM FQI1. 7 
Immunoprecipitation (IP) and immunofluorescence experiments were carried out as 8 
described previously (Andrews and Faller, 1991;Estève et al., 2006). For the 9 
immunoprecipitation, 1 mg of total HEK293T cellular extract was incubated with 5 μg of anti-10 
SET8 antibody (Active Motif, 61009), anti-LSF antibody (Millipore,17-10252), or mouse anti-11 
FLAG antibody (F1804, Sigma-Aldrich). The immunoprecipitates were blotted with anti-α-12 
tubulin, anti-β-tubulin (Sigma T9026, T8328), anti-SET8 (Abcam, ab3798), anti-Pr-Set7 (D11) 13 
(Santa Cruz, sc-377034), anti-LSF (BD Biosciences) antibodies or anti-FLAG (CST, 14793), as 14 
per the manufacturer’s dilution recommendations. Cellular extracts were also 15 
immunoprecipitated with normal IgG (Cell Signaling Technology) as a negative control for all IP 16 
experiments.  17 
For immunofluorescence to detect α-tubulin and SET8 co-localization, COS7 cells were 18 
grown on coverslips and transfected with a GFP-SET8 expression plasmid. After cells were fixed 19 
with paraformaldehyde, the cells were incubated with anti-α-tubulin and the microtubules 20 
visualized with an anti-mouse IgG coupled with Alexa Fluor 488 (Molecular Probes) using a 21 
confocal microscope (Zeiss LSM510). For the detection of SET8 and LSF co-localization, COS7 22 
cells were co-transfected with GFP-SET8 and 3XFlag-LSF expression plasmids; the epitope 23 
tagged LSF was detected by mouse anti-FLAG antibody (F3165, Sigma-Aldrich) and visualized 24 
with an anti-mouse IgG coupled with Alexa Fluor 488 (Molecular Probes). DAPI was used to 25 
stain nuclear DNA. For analysis of FQI1 effects on mitosis, paraformaldehyde-fixed cells were 26 
analyzed for microtubules with anti-α-tubulin antibody (Abcam #AB7750) and stained with 27 
DAPI  (Invitrogen) for visualizing genomic DNA. Samples were imaged using a Zeiss 28 
Axioimager M1 microscope utilizing 63x and 100x magnifications. 29 
 30 
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GST and MBP pull down assays 1 
LSF, SET8 and α-tubulin cDNAs were cloned into the pGEX-5X-1 (GE Healthcare) or 2 
pMalC4X (New England Biolabs) vector and GST-tagged or MBP-tagged proteins were 3 
captured using Glutathione Sepharose beads (GE Healthcare) or amylose resin (New England 4 
Biolabs), respectively. Sepharose beads containing approximately 10 μg of fusion protein were 5 
incubated for 2 hours at 4°C with purified tubulin (MP-biomedical), recombinant His-tagged 6 
LSF, or recombinant His-tagged SET8, the latter two being purified from E. coli. Proteins bound 7 
to the beads were resolved by 10-20% SDS-PAGE. LSF, SET8 and α-tubulin were visualized by 8 
immunoblotting by using anti-LSF (BD Biosciences), anti-SET8 (Active Motif) or anti-α-tubulin 9 
(Sigma-Aldrich), respectively. 10 
 11 
In vitro methylation assays 12 
Approximately 1 μg of recombinant GST-SET8 (in 50% glycerol) and 2 μg of the purified 13 
tubulin (MP-Bioscience, #0877115), recombinant MBP-α-tubulin, or recombinant MBP-β-14 
tubulin were incubated with 6 µM radioactively labeled [3H] AdoMet (Perkin Elmer 15 
#NET155V001MC) in 1X HMT buffer containing 5 mM Tris pH 8.0, 0.5 mM DTT at room 16 
temperature for overnight. As indicated, histone H4 (NEB #2504S), recombinant His-LSF 17 
protein, or FQI1 inhibitor were added to the reaction. Samples were separated by electrophoresis 18 
through a 10% Tricine Gel (Invitrogen) and the gel was stained with Coomassie Brilliant Blue 19 
(shown in grayscale in the figures) and incubated with EN3HANCE (PerkinElmer) solution. The 20 
gel was dried and exposed to autoradiography film for 1 week. For the peptide assays, the 21 
specific peptides of α-tubulin were synthesized from AnaSpec Inc. Sequences are listed in 22 
Appendix Table S2. Two μg of each peptide and 2 μg of purified wild type or mutant SET8 or 23 
full-length SETD2 (Active Motif) were incubated with radioactively labeled [3H] AdoMet at 24 
room temperature overnight. Samples were spotted onto P81 filters (Whatman 3698325) and the 25 
filters were washed 3 times with 0.3 M ammonium bicarbonate. The level of incorporated 26 
[3H]CH3 was determined using liquid scintillation counting. 27 
 28 
Mass-spectrometric analysis 29 
For identification of proteins in the tubulin preparations, >97% purified porcine tubulin 30 
(rPeptide, # T-1201-1) and >99% purified bovine tubulin (MP-Bioscience, #0877112) were 31 
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separated by electrophoresis through a 10-20% Tris-Glycine polyacrylamide gel. The gel was 1 
stained with Coomassie Blue; sections of the gels around 55 kDa, and below 55 kDa, 2 
respectively, were excised (Appendix Fig S1A). Excised gel band were analyzed by the Taplin 3 
Mass Spectrometry Facility, Harvard Medical School. For identification of tubulin 4 
modifications, purified tubulin (MP-Bio, #0877115) was incubated with nonradioactive AdoMet, 5 
with or without recombinant GST-SET8, overnight at room temperature and the samples were 6 
separated by electrophoresis through a 10% Tris-glycine gel. Excised gel bands were digested 7 
with either subtilisin or trypsin in 0.01% ProteaseMax in 50 mM NH4HCO3 for 1 hr at 50°C. 8 
Digestion was quenched with trifluoroacetic acid and samples were dried.  Each digest was 9 
individually reconstituted and analyzed by direct injection onto an analytical column 25 cm 100 10 
µm ID Aqua 3 µm with Easy n1000 nLC-QExactive at 300 nL/min. Acquired HCD spectra were 11 
searched using Proteome Discoverer 2.0 and SWISSPROT June 2015 database using nonspecific 12 
cleavage and Cys = 57.02146 static modification. Dynamic modifications were set for Met = 13 
15.99492. Searches were semi-specific with K= 14.016 dynamic modification. Results were 14 
filtered with Percolator for high confidence spectrum matches. 15 
 16 
Biochemical fractionation of HEK293T cells 17 
Subcellular fractions from cultured HEK293T cells were obtained using the Cell Fractionation 18 
Kit (CST, #9038) according to the manufacturer’s protocol. Cytoplasm, nuclear, and whole cell 19 
extracts were separated by electrophoresis through a 10-20% 10-20% Tris-Glycine and the 20 
resulting membrane immunoblotted with anti-MEK1/2 (D1A5, #8727), Anti-histone H3(CST, 21 
#9715), anti-β-actin (CST, #4970), anti-SET8 (Active Motif, #61009).   22 
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Figure Legends 1 
Figure 1. SET8 associates with tubulin in cells and directly interacts with α-tubulin in vitro. 2 
A Colocalization of SET8 and α-tubulin in COS7 cells. GFP-SET8 (green) was expressed in 3 
asynchronous cells, tubulin was detected with anti-α-tubulin antibody (red) and DNA 4 
with DAPI (blue). Yellow in the merged image indicates colocalization of SET8 and 5 
α-tubulin. Images are from cells identified as being in the indicated stages of cell cycle 6 
progression. Scale bars: 10 µm. 7 
B  Endogenous SET8 is localized in both nucleus and cytoplasm in HEK293T cells. Whole 8 
cell extract (WCE), cytoplasmic, and nuclear fractions were separated and analyzed for 9 
the presence of SET8, β-actin (present in both), MEK1/2 (predominantly cytoplasmic 10 
marker), and histone H3 (nuclear marker). 11 
C Co-immunoprecipitation from HEK293T cells of endogenous tubulins with endogenous 12 
SET8, using SET8 antibody (Ab). Right lane: >99% pure tubulin (MP Biomedical, 13 
#0877112) as a positive control. Immunoprecipitates were analyzed using antibodies 14 
against the indicated proteins by immunoblotting (IB). 15 
D Co-immunoprecipitation from HEK293T cells of endogenous SET8 with transiently 16 
expressed Flag-tagged tubulins, as detected by immunoprecipitation with antibody 17 
against Flag.  18 
E MBP-pull down analysis of purified His-SET8 with MBP-α-tubulin, but not MBP-19 
β-tubulin. Top: Immunoblot (IB) in which biotinylated molecular weight markers are 20 
visualized; bottom: Coomassie staining of the same gel (shown in grayscale) in which 21 
standard molecular weight markers are visualized. *Expected positions of migration of 22 
the MBP-proteins. 23 
F GST-pull down analysis of purified porcine brain tubulin to full-length or the indicated 24 
overlapping segments of SET8 fused to GST. Top: immunoblot (IB) in which 25 
biotinylated molecular weight markers are visualized; bottom: Ponceau staining of the 26 
same gels (shown in grayscale) in which standard molecular weight markers are 27 
visualized. *Expected positions of migration of the GST-proteins. 28 
 29 
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Figure 2. Histone methytransferase SET8 methylates α-tubulin at K311. 1 
A Purified porcine tubulin (rPeptide, # T-1201-1) is methylated by SET8. Lane 1: histone 2 
H4 (1 µg) was added in addition to tubulin as substrates. Top: autoradiogram of 3 
methyltransferase assays, showing methylation of tubulin (*), histone H4, and 4 
automethylation of GST-SET8. # indicates the migration of [3H]-labeled impurities, 5 
which migrated at a similar position to that of Histone H4. Bottom: Coomassie-staining 6 
of the same gel (shown in grayscale) indicating relative levels of the components in the 7 
reaction. 8 
B Recombinant human MBP-α-tubulin (*), but not MBP-β-tubulin, is methylated by SET8. 9 
Autoradiogram (top) and Coomassie-staining (bottom) are as described in A. Protein 10 
bands <50 kDa are from the purified GST-SET8 preparation, and are more evident in this 11 
experiment than in other reactions. 12 
C Mass spectrum and table of expected m/z of the peptide fragments (with observed 13 
fragments in red) confirming methylation on K311 of α-tubulin after incubation of 14 
purified tubulin with SET8.  15 
D The 3-dimensional structure of the α/β-tubulin heterodimer (PDB ID 1JFF; purple: 16 
α-tubulin; blue: β-tubulin), indicating positions of lysines in α-tubulin targeted by SET8 17 
in vitro (green). Inside and outside surfaces of the MT structure are indicated. 18 
E Mutation solely of K311 in recombinant MBP-α-tubulin (K311S) substantially reduced 19 
methylation by GST-SET8 in vitro. Autoradiogram (top) and Coomassie-staining 20 
(bottom) are as described in A. 21 
 22 
Figure 3. LSF interacts directly with SET8 and tubulin.  23 
A GST-pull down analysis of purified His-LSF to full-length or the indicated overlapping 24 
segments of SET8 fused to GST. Top: immunoblot (IB) in which biotinylated molecular 25 
weight markers are visualized; bottom: Ponceau staining of the same gels (shown in 26 
grayscale) in which standard molecular weight markers are visualized. *Expected 27 
positions of migration of the GST-proteins. 28 
B GST-pull down analysis of purified porcine tubulin to purified full-length or the indicated 29 
overlapping segments of LSF fused to GST. Gels are as described in A. * or bracket: 30 
Expected positions of migration of the GST-proteins. 31 
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C GST-pull down analysis of recombinant, purified His-tagged LSF to purified α-tubulin 1 
fused to GST. Gels are as described in A, except that the protein gel was stained with 2 
Coomassie. 3 
D  Plasmids expressing 3xFLAG-LSF and GFP-SET8 were transfected into COS7 cells. 4 
Anti-FLAG antibody was visualized with a red fluorescing secondary antibody, and DNA 5 
was visualized with DAPI. The merged image indicates colocalization of GFP-SET8 with 6 
FLAG-LSF (yellow), concentrated largely near the nuclear membrane (Manders 7 
correlation coefficient of LSF and SET8 colocalization is 0.9, as determined via the 8 
Image J 3D analysis). The majority of overexpressed 3XFlagLSF was cytoplasmic with 9 
only a minority detected in the nucleus. 10 
E Specific co-immunoprecipitation of endogenous SET8 (top) and endogenous α-tubulin 11 
(bottom) from HEK293 cellular extracts, using antibodies to LSF as compared to control 12 
IgG. 13 
F Specific co-immunoprecipitation of endogenous LSF from HEK293 cellular extracts, 14 
using antibodies to SET8 as compared to control IgG. 15 
G Immunoblotting of purified porcine brain tubulin (rPeptide, >97%) shows the presence of 16 
LSF, using a LSF monoclonal antibody. Representative also of results obtained using a 17 
separate source of purified tubulin: MP Biomedical >99%. Positive control for LSF 18 
migration: 293T WCE (HEK293T cell whole cell extract). Top: immunoblot; bottom: 19 
Ponceau staining using standard molecular weight markers. 20 
 21 
Figure 4. LSF and FQI1 oppositely affect methylation of tubulin by SET8.  22 
A Tubulin (>99%, MP Biomedical) methylation reactions were performed with addition of 23 
the indicated, increasing range of concentrations of LSF. Top: autoradiogram of 24 
methyltransferase assays, showing methylation of tubulin (*) and automethylation of 25 
GST-SET8. The higher relative levels of GST-SET8 to α/β-tubulin in this experiment led 26 
to greater initial automethylation of SET8 relative to tubulin methylation. # indicates the 27 
migration of [3H]-labeled impurities. Bottom: Coomassie-staining of the same gel (shown 28 
in grayscale) indicating relative levels of the components in the reaction. As in Fig 2B, 29 
protein bands <50 kDa are from the purified GST-SET8 preparation, and are more 30 
evident in this experiment.  31 
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B Co-immunoprecipitation of endogenous α-tubulin with endogenous LSF from HEK293T 1 
cell lysates was disrupted upon treatment of the cells with 2.5 μM FQI1 for 24 hr. 2 
C Tubulin (>99%, MP Biomedical) methylation reactions were performed with addition of 3 
the indicated, increasing range of concentrations of FQI1. At 100 µM FQI1 (lane 4), 4 
methylation is decreased ~3-fold. Gels are labeled as in A. 5 
D Histone H4 methylation reactions at limiting amounts of histone H4 (200 ng) were 6 
performed with addition of the indicated, increasing range of concentrations of FQI1. 7 
Gels are labeled as in A. 8 
E Model for the recruitment and/or activation of SET8 at microtubules by LSF, and the 9 
subsequent methylation of α-tubulin by SET8. 10 
  11 
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